62
10
11
0
Hashtag
#aiCART
Advertisement · 728 × 90
The bispecific antibody teclistamab was recently studied for resistance, with variant R27P mediating antigen escape (PMID 37653344). Resistance emerges after 9 months in most patients. Our binder B10, with a different predicted binding interface, enabled #aiCART cells to kill BCMA-R27P cells. (6)
4
0
1
0